524400 — Ishita Drugs And Industries Balance Sheet
0.000.00%
Last trade - 00:00- IN₹216.02m
- IN₹129.05m
- IN₹149.97m
- 77
- 48
- 54
- 66
Annual balance sheet for Ishita Drugs And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 54.2 | 84.8 | 65.5 | 78.7 | 83.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 18.9 | 5.75 | 20 | 7 | 21.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 79.9 | 100 | 102 | 96.6 | 150 |
| Net Property, Plant And Equipment | 9.96 | 8.85 | 8.89 | 8.05 | 8.79 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 92.6 | 113 | 114 | 108 | 163 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14.3 | 26.3 | 22.1 | 8.67 | 54 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 14.7 | 26.6 | 22.3 | 8.87 | 55.1 |
| Common Stock | |||||
| Other Equity | |||||
| Total Equity | 77.9 | 86 | 91.7 | 99.2 | 108 |
| Total Liabilities & Shareholders' Equity | 92.6 | 113 | 114 | 108 | 163 |
| Total Common Shares Outstanding |